HCA Healthcare Inc

Chart & Performance

D1W1MN

P/E

14.20

P/S

1.16

EPS

23.40

Div Yield, %

0.60%

Shrs. gr., 5y

-5.55%

Rev. gr., 5y

6.58%

Revenues

70.60b

+8.67%

Net income

5.76b

+9.88%

CFO

10.51b

+11.48%

Dividend

Sep 16, 20240.66 USD/sh

Earnings

Apr 24, 2025

Profile

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

URL

https://hcahealthcare.com/

IPO date

Dec 28, 2010

Employees

207,000

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	70,603,000 8.67%	64,968,000 7.86%	60,233,000 2.52%
Cost of revenue		84,828,000	37,056,000
Unusual Expense (Income)
NOPBT	70,603,000	(19,860,000)	23,177,000
NOPBT Margin	100.00%		38.48%
Operating Taxes	1,866,000	1,615,000	1,746,000
Tax Rate	2.64%		7.53%
NOPAT	68,737,000	(21,475,000)	21,431,000
Net income	5,760,000 9.88%	5,242,000 -7.11%	5,643,000 -18.88%
Dividends	(690,000)	(661,000)	(653,000)
Dividend yield	0.88%	0.88%	0.92%
Proceeds from repurchase of equity	(6,042,000)	(3,811,000)	(7,000,000)
BB yield	7.69%	5.09%	9.90%
Debt
Debt current	4,698,000	2,787,000	370,000
Long-term debt	42,059,000	41,338,000	41,218,000
Deferred revenue
Other long-term liabilities	3,585,000	3,424,000	3,143,000
Net debt	43,593,000	41,836,000	39,476,000
Cash flow
Cash from operating activities	10,514,000	9,431,000	8,522,000
CAPEX	(4,875,000)	(4,744,000)	(4,395,000)
Cash from investing activities	(4,933,000)	(5,317,000)	(3,389,000)
Cash from financing activities	(4,582,000)	(4,094,000)	(5,656,000)
FCF	67,112,000	(24,973,000)	19,510,000
Balance
Cash	1,933,000	1,022,000	908,000
Long term investments	1,231,000	1,267,000	1,204,000
Excess cash
Stockholders' equity	552,000	1,060,000	(73,000)
Invested Capital	49,034,000	46,343,000	42,608,000
ROIC	144.14%		51.24%
ROCE	143.99%		54.49%
EV
Common stock shares outstanding	261,806	276,412	294,666
Price	300.15 10.89%	270.68 12.80%	239.96 -6.60%
Market cap	78,581,071 5.03%	74,819,200 5.81%	70,708,053 -16.29%
EV	125,228,071	119,489,200	112,878,053
EBITDA	73,915,000	(16,783,000)	26,146,000
EV/EBITDA	1.69		4.32
Interest	2,061,000	1,938,000	1,741,000
Interest/NOPBT	2.92%		7.51%